Find the Perfect Plan for Your Investment Journey
1
Latest price
52 Week Range
CA$0.20 - CA$1.25
Next Earnings Date
Apr 28 2025
Next Earnings Date
Apr 28 2025
Latest price
Market Cap | CA$38.85M |
EV | CA$41.14M |
Shares Outstanding | 117.74M |
Beta | 1.84 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 451.10% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | 2.35% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
1
1CM Inc.
EPIC
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Bhandari, Tanvi
Employees
Website
1cminc.comIPO Date
2012-02-22
Headquarters
625 Cochrane Drive, Suite 802, Markham, Ontario, L3R 9R9, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved